Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-Analysis
- PMID: 36765701
- PMCID: PMC9913680
- DOI: 10.3390/cancers15030743
Performance of Radiomics in Microvascular Invasion Risk Stratification and Prognostic Assessment in Hepatocellular Carcinoma: A Meta-Analysis
Abstract
Background: Primary liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer death. Advances in phenomenal imaging are paving the way for application in diagnosis and research. The poor prognosis of advanced HCC warrants a personalized approach. The objective was to assess the value of imaging phenomics for risk stratification and prognostication of HCC.
Methods: We performed a meta-analysis of manuscripts published to January 2023 on MEDLINE addressing the value of imaging phenomics for HCC risk stratification and prognostication. Publication information for each were collected using a standardized data extraction form.
Results: Twenty-seven articles were analyzed. Our study shows the importance of imaging phenomics in HCC MVI prediction. When the training and validation datasets were analyzed separately by the random-effects model, in the training datasets, radiomics had good MVI prediction (AUC of 0.81 (95% CI 0.76-0.86)). Similar results were found in the validation datasets (AUC of 0.79 (95% CI 0.72-0.85)). Using the fixed effects model, the mean AUC of all datasets was 0.80 (95% CI 0.76-0.84).
Conclusions: Imaging phenomics is an effective solution to predict microvascular invasion risk, prognosis, and treatment response in patients with HCC.
Keywords: hepatocellular carcinoma; imaging phenomics; radiomics; risk stratification and prognostication.
Conflict of interest statement
Dr Yan Liu is an employee of Median Technology. The other authors declare no conflicts of interest.
Figures





Similar articles
-
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.Eur Radiol. 2019 Jul;29(7):3595-3605. doi: 10.1007/s00330-018-5985-y. Epub 2019 Feb 15. Eur Radiol. 2019. PMID: 30770969
-
Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.Quant Imaging Med Surg. 2021 May;11(5):1836-1853. doi: 10.21037/qims-20-218. Quant Imaging Med Surg. 2021. PMID: 33936969 Free PMC article.
-
Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics.World J Gastroenterol. 2021 May 7;27(17):2015-2024. doi: 10.3748/wjg.v27.i17.2015. World J Gastroenterol. 2021. PMID: 34007136 Free PMC article. Clinical Trial.
-
Research progress of MRI-based radiomics in hepatocellular carcinoma.Front Oncol. 2025 Feb 6;15:1420599. doi: 10.3389/fonc.2025.1420599. eCollection 2025. Front Oncol. 2025. PMID: 39980543 Free PMC article.
-
Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis.Front Oncol. 2020 Jun 26;10:887. doi: 10.3389/fonc.2020.00887. eCollection 2020. Front Oncol. 2020. PMID: 32676450 Free PMC article.
Cited by
-
CT and MRI of abdominal cancers: current trends and perspectives in the era of radiomics and artificial intelligence.Jpn J Radiol. 2024 Mar;42(3):246-260. doi: 10.1007/s11604-023-01504-0. Epub 2023 Nov 6. Jpn J Radiol. 2024. PMID: 37926780 Review.
-
Dynamic radiomics based on contrast-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma.BMC Med Imaging. 2024 Apr 8;24(1):80. doi: 10.1186/s12880-024-01258-9. BMC Med Imaging. 2024. PMID: 38584254 Free PMC article.
-
Robotic navigation-assisted percutaneous liver puncture: a pilot study.Quant Imaging Med Surg. 2025 Feb 1;15(2):1543-1554. doi: 10.21037/qims-24-1584. Epub 2025 Jan 22. Quant Imaging Med Surg. 2025. PMID: 39995746 Free PMC article.
-
The role of artificial intelligence and image processing in the diagnosis, treatment, and prognosis of liver cancer: a narrative-review.Prz Gastroenterol. 2024;19(3):221-230. doi: 10.5114/pg.2024.143147. Epub 2024 Sep 18. Prz Gastroenterol. 2024. PMID: 39802971 Free PMC article. Review.
References
-
- The Nordic Cochrane Centre . The Nordic Cochrane Centre; Copenhagen, Denmark: 2014. The Cochrane Collaboration Review Manager (RevMan) [Computer Program], Version 5.3.
Publication types
LinkOut - more resources
Full Text Sources